polypharmacy

Jeffery, A., Bhanu, C., Walters, K., Wong, I. C., Osborn, D., & Hayes, J. F. (2023). Polypharmacy and antidepressant acceptability in comorbid depression and type 2 diabetes: a cohort study using UK primary care data. Br J Gen Pract, 73, e392-e398. http://doi.org/10.3399/bjgp.2022.0295

View

Subramanian, A., Azcoaga-Lorenzo, A., Anand, A., Phillips, K., Lee, S. I., Cockburn, N., et al. (2023). Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019. Bmc Med, 21, 21. http://doi.org/10.1186/s12916-022-02722-5

View

Elhussein, L., Jödicke, A. M., He, Y., Delmestri, A., Robinson, D. E., . Y. Strauss, V., & Prieto-Alhambra, D. (2023). Characterising complex health needs and the use of preventive therapies in the older population: a population-based cohort analysis of UK primary care and hospital linked data. Bmc Geriatr, 23, 58. http://doi.org/10.1186/s12877-023-03770-z

View

Jeffery, A., Bhanu, C., Walters, K., Wong, I. C. K., Osborn, D., & Hayes, J. F. (2022). Association between polypharmacy and depression relapse in individuals with comorbid depression and type 2 diabetes: a UK electronic health record study. Br J Psychiatry, 1-7. http://doi.org/10.1192/bjp.2022.160

View